Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Asset Utilization Ratio (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.04 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 6.51% to 0.04 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.04, a 6.51% increase, with the full-year FY2024 number at 0.03, up 6.4% from a year prior.
  • Asset Utilization Ratio was 0.04 for Q3 2025 at Orchestra BioMed Holdings, down from 0.06 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.06 in Q2 2025 to a low of 0.02 in Q1 2024.
  • A 4-year average of 0.04 and a median of 0.03 in 2023 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 39.36% in 2023, then surged 115.46% in 2025.
  • Orchestra BioMed Holdings' Asset Utilization Ratio stood at 0.04 in 2022, then crashed by 39.36% to 0.03 in 2023, then surged by 33.48% to 0.03 in 2024, then rose by 9.62% to 0.04 in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Asset Utilization Ratio are 0.04 (Q3 2025), 0.06 (Q2 2025), and 0.04 (Q1 2025).